BRIEF published on 11/19/2025 at 13:52, 15 days 16 hours ago Guerbet's 2026 Financial Calendar Financial Calendar Guerbet Medical Imaging Annual Results General Assembly
PRESS RELEASE published on 11/19/2025 at 13:47, 15 days 16 hours ago GUERBET : Financial agenda for 2026 Guerbet announces financial agenda for 2026 with key dates for publications and meetings in the medical imaging sector Financial Agenda Guerbet Medical Imaging Publications 2026
BRIEF published on 09/25/2025 at 09:26, 2 months 9 days ago GUERBET: Publication of the 2025 Half-Yearly Financial Report Financial Report Guerbet Medical Imaging 2025 Contrast Agents
BRIEF published on 09/22/2025 at 17:50, 2 months 12 days ago Guerbet Announces Interim CEO Amid Leadership Change Interim CEO Guerbet Medical Imaging Leadership Change Jerome Estampes
PRESS RELEASE published on 09/22/2025 at 17:45, 2 months 12 days ago Guerbet : Change in General Management Guerbet appoints Jérôme Estampes as interim CEO, replacing David Hale. Smooth transition expected with Executive Committee support. Nominations process underway for new CEO CEO Appointment Guerbet Transition Jerome Estampes Nominations Process
BRIEF published on 09/15/2025 at 17:55, 2 months 19 days ago Guerbet Revises 2025 Financial Outlook Downward Financial Targets Revenue Decline Guerbet Imaging Solutions 2025 Outlook
PRESS RELEASE published on 09/15/2025 at 17:50, 2 months 19 days ago Guerbet : Adjustment of 2025 full-year financial targets Guerbet revises downward its 2025 financial targets due to supply reforms, customer mix shift, and operational issues. Revenue to decline, EBITDA margin revised, and free cash flow expected negative Financial Targets Revenue Decline Guerbet 2025 Downward Revision
BRIEF published on 08/13/2025 at 17:50, 3 months 22 days ago Guerbet: Capital Situation as of July 31, 2025 Share Capital Voting Rights AMF Treasury Shares Guerbet
BRIEF published on 05/26/2025 at 08:47, 6 months 9 days ago Guerbet revises its Board of Directors Board Of Directors Independent Director Appointment Guerbet Mandate
PRESS RELEASE published on 05/26/2025 at 08:42, 6 months 9 days ago Guerbet : Changes in the composition of the Guerbet board of directors. Guerbet reorganizes Board of Directors with appointment and reappointment of independent directors and reduction of terms to 4 years, following the AGM decisions Board Of Directors Reorganization AGM Guerbet Independent Directors
Published on 12/05/2025 at 02:35, 3 hours 38 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 13 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 8 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 13 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 2 hours 42 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 22 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 47 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 58 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 2 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours 13 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 28 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 29 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 12 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025
